FDA Approves Lifesaving Treatment For Drug-Resistant Tuberculosis, Hard-To-Cure Patients

Pretomanid, approved for use with two other antibiotics, will be used for the toughest cases. Tuberculosis has surpassed AIDS as the world's leading cause of infectious death. The drug was developed by a nonprofit group called TB Alliance at a time when few companies are investing in creating next-generation antibiotics.

from Kaiser Health News https://ift.tt/2YSsUti